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Myosmine [3-(1-pyrrolin-2-yl) pyridine] is an alkaloid structurally similar to nicotine, which is known to 
induce oxidative stress. In this study we investigated the effects of myosmine on enzymatic and non-
enzymatic antioxidative defence in rat liver. Wistar rats received a single i.p. injection of 19 mg kg-1 of 
myosmine and an oral dose of 190 mg kg-1 by gavage. Nicotine was used as a positive control. Through 
either route of administration, myosmine altered the hepatic function by decreasing the levels of reduced 
glutathione, superoxide dismutase, and glutathione peroxidase activities on one hand and by increasing 
malondialdehyde, catalase, and glutathione reductase activity on the other. Compared to control, both 
routes caused signifi cant lipid peroxidation in the liver and altered hepatic enzymatic and non-enzymatic 
antioxidative defences. The pro-oxidant effects of myosmine were comparable with those of nicotine.
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Myosmine [3-(1-pyrrolin-2-yl) pyridine] is the 
second tobacco alkaloid to nicotine (1). However, 
myosmine has a much wider distribution over a wide 
variety of food products such as maize, rice, wheat, 
cocoa, and milk in a wide range of mass fractions from 
0.03 ng g-1 in carrots up to 6.26 ng g-1 in cream (2). It 
is therefore not surprising that myosmine has also been 
detected in human toenail, plasma (up to 5.5 ng mL-1), 
saliva (up to 4.6 ng mL-1) (3) or breast milk (4). When 
given orally to Wistar rats, myosmine is metabolised 
rapidly and completely (5). After nitrosation and/or 
peroxidation, myosmine bioactivates to 4-hydroxy-1-
(3-pyridyl)-1-butanone (HPB) and can form 
pyridyloxobutylated DNA adducts (6) or N’-
nitrosonornicotine (NNN), which is an oesophageal 
carcinogen (7). In vitro experiments with calf thymus 
DNA have shown that myosmine is rapidly nitrosated 
at pH 2 to pH 4 and forms DNA adducts (8). Using 
the comet assay in human lymphocytes and upper 
aerodigestive tract epithelial cells, Kleinsasser et al. 
(9) have demonstrated dose-and time-dependent 
genotoxic effects of myosmine.
While there are some data about the potential 
genotoxic and carcinogenic effects of myosmine, little 
information is available about its toxicity. Organ 
toxicity of nicotine is known to be related to oxidative 
stress (10). We assume that because of its structural 
similarity to nicotine, myosmine might exert similar 
toxicity by generating reactive oxygen species 
(ROS).
Zwickenpfl ug and Tyroller (6) have suggested that 
because of its imine structure, myosmine seems to be 
more reactive than other investigated tobacco 
alkaloids. The authors have shown that when 
myosmine is mixed with hydrogen peroxide, the latter 
attacks the carbon nitrogen double bond of the imine 
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structure, yielding oxaziranes, nitrones, or N-oxides. 
These metabolic intermediates might be involved in 
oxidative stress.
The aim of our study was to investigate the effects 
of myosmine on the enzymatic and non-enzymatic 
antioxidative defences in rat liver after a single oral 
and intraperitoneal (i.p.) administration.
MATERIAL AND METHODS
Chemicals and enzymes
Myosmine was synthesised at the Institute of 
Molecular Biology, Bulgarian Academy of Science 
(BAS), following the method of Brandänge and 
Lindblom (11). The product was found to be 99.9 % 
pure; its identity was confi rmed by comparing it with 
commercial myosmine using ultraviolet and infrared 
spectral analysis, gas chromatography, and high 
pressure liquid chromatography. All the other reagents 
used were of analytical grade. Nicotine dihydrogen 
ditartrate (CAS 65-31-6), 1-chloro-2,4-dinitrobenzene 
(CDNB), ß-nicotinamide adenine dinucleotide 2’-
phosphate reduced tetrasodium salt (NADPH), 
ethylenediaminetetraacetic acid (EDTA), L-glutathione 
reduced (GSH), L-glutathione oxidised (GSSG), 
cumene hydroperoxide, thiobarbituric acid (TBA), 
trichloroacetic acid (TCA), bovine serum albumin 
(fraction V), glutathione reductase from baker’s yeast 
(S. cerevisiae) ammonium sulfate suspension, 100 to 
300 units mg-1 protein (Biuret) were purchased from 
Sigma-Aldrich (Taufkirchen, Germany). 2,2’-Dinitro-
5,5’-dithiodibenzoic acid (DTNB) was obtained from 
Merck (Darmstadt, Germany).
Experimental animals
Male Wistar rats weighing (200±10) g were housed 
under standard laboratory conditions at 20 °C, with 
12-h alternating light/dark cycles and free access to 
food and water. The animals were purchased from the 
National Breeding Centre, Slivnitza, Bulgaria. All 
experiments were performed after at least one week 
of adaptation to this environment. All procedures were 
approved by the Institutional Animal Care Committee, 
and the principles stated in the European Convention 
for the Protection of Vertebrate Animals used for 
Experimental and other Scientifi c Purposes (ETS 123) 
(12) were strictly followed throughout the ex-
periment.
Experimental design
Earlier studies have shown that the i.p. and oral 
LD50 of myosmine for rats is 190 mg kg
-1 and 
1875 mg kg-1, respectively (13). Before starting the 
experiment, we ran a pilot study to establish the dose-
related effect of myosmine on animal behaviour and 
liver ALT, AST, and LDH (the results are not shown). 
A single dose of 1/5, 1/10, or 1/20 of LD50 of myosmine 
was administered i.p. and orally to six groups of three 
rats per group. The dose of 1/20 of LD50 did not show 
any statistically signifi cant behavioural or biochemical 
changes. The dose of 1/5 of LD50 proved very toxic 
(2 of 3 rats died after i.p. injection and 1 of 3 after oral 
administration) and the dose of 1/10 of LD50 was well 
tolerated and at the same time produced signifi cant 
changes in the investigated parameters. This is why 
we used the dose 1/10 of LD50 for both routes of 
administration. For positive control we used nicotine 
ditartrate in an equitoxic dose of 1/10 of LD50 (14).
The rats were then randomised into six groups with 
six animals in each. Group 1 were control rats treated 
with physiological saline i.p. (1 mL kg-1 b. w.). Group 
2 were control rats given physiological saline via oral 
gavage (10 mL kg-1 b. w.). Group 3 were rats injected 
with nicotine dihydrogen ditartrate i.p. (1 mg kg-1 b. 
w.). Group 4 were rats administered nicotine dihydrogen 
ditartrate through oral gavage (6.5 mg kg-1 b. w.). 
Group 5 were rats injected myosmine i.p. (19 mg kg-1 
b. w.), and group 6 were rats administered myosmine 
through oral gavage (190 mg kg-1 b. w.).
Twenty-four hours after the administration of the 
single dose, the animals were killed by cervical 
dislocation. Tissue samples were immediately 
transferred to ice-cold containers, weighed, and 
homogenised using appropriate buffers (15).
Preparation of liver homogenates for lipid 
peroxidation (LPO) assessment
Thiobarbituric acid reactive substances (TBARS), 
expressed as malondialdehyde (MDA) equivalents, 
were determined as a marker of lipid peroxidation. 
The method was described by Polizio and Peña (15). 
Briefl y, 1 mL of homogenate was mixed with 1 mL of 
25 % trichloroacetic acid (TCA) and 1 mL of 0.67 % 
thiobarbituric acid (TBA). Samples were then mixed 
thoroughly, heated in a boiling water bath for 20 min, 
cooled down, and centrifuged at 4000g for 20 min. 
The absorbance of supernatant was measured at 
535 nm against a blank that contained all the reagents 
except tissue homogenate. MDA concentration was 
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calculated using a molar extinction coeffi cient of 
1.56x105 L mol-1 cm-1 and expressed in nmol g-1 of wet 
tissue.
Preparation of liver homogenates for reduced 
glutathione (GSH) assessment
GSH was assessed by measuring non-protein 
sulfhydryls after precipitation of proteins with TCA, 
using the method described by Bump et al. (16). 
Briefl y, tissues were homogenised in 5 % TCA and 
then centrifuged at 4000g for 20 min. The reaction 
mixture contained 0.05 mL of supernatant, 3 mL of 
0.05 mol L-1 phosphate buffer (pH 8), and 0.02 mL of 
DTNB reagent. The absorbance was determined at 
412 nm and the results expressed as nmol g-1 wet 
tissue.
Preparation of liver homogenates for antioxidant 
enzyme activity measurement
Rat livers were rinsed in ice-cold physiological 
saline and minced with scissors. Ten-percent 
homogenates were prepared in 0.05 mol L-1 phosphate 
buffer (pH 7.4), centrifuged at 7000g for 10 minutes, 
and the supernatants used for antioxidant enzyme 
analysis. The protein content of liver homogenates 
was measured using the method of Lowry (17) with 
bovine serum albumin as a standard.
Catalase (CAT) activity
CAT activity was assessed as described by Aebi 
(18). Briefl y, 10 μL of homogenate was added to 
1990 μL of H2O2 solution (containing 6.8 μL of 30 % 
H2O2 + 1983.2 μL 0.05 mol L
-1 phosphate buffer, at 
pH 7.4). CAT activity was determined by measuring 
H2O2 decomposition through the decrease in absorbance 
at 240 nm for 1 min. Enzyme activity was calculated using 
the molar extinction coefficient of 0.043 L mmol-1
cm-1 and expressed as μmol L-1 min-1 mg-1 of 
protein.
Superoxide dismutase (SOD) activity
SOD activity was measured according to Sun and 
Zigman (19) with slight modifi cations. The incubation 
mixture contained 50 mmol L-1 carbonate buffer with 
pH 10.2 at 30 °C. The reaction was started by adding 
epinephrine base (0.001 mol L-1 in 0.02 mol L-1 HCl). 
Epinephrine auto-oxidat ion was fol lowed 
spectrophotometrically at 320 nm, using the molar 
extinction coeffi cient of 4.02 L mmol-1 cm-1. SOD 
activity is expressed as nanomol of epinephrine that 
are prevented from auto-oxidation after addition of 
the sample.
Glutathione peroxidase (GPx) activity
GPx activity was measured by NADPH oxidation, 
using a coupled reaction system consisting of reduced 
glutathione, glutathione reductase and cumene 
hydroperoxide (20). Briefl y, 100 μL of enzyme sample 
was incubated at 30 °C for 5 min with 1.5 mL of 
0.05 mol L-1 phosphate buffer (pH 7.4), 100 μL of 
1 mmol L-1 EDTA, 50 μL of 1 mmol L-1 GSH, 100 μL 
of 0.2 mmol L-1 NADPH, and 1 U of glutathione 
reductase. The reaction was initiated by adding 50 μL 
of cumene hydroperoxide (1 mg mL-1) and the rate of 
disappearance of NADPH over time was determined 
by monitoring absorbance at 340 nm using an 
extinction coeffi cient of 6.22x103 L mol-1 cm-1. The 
results are expressed in nmol min-1 mg-1 of protein.
Glutathione reductase activity (GR)
GR activity was measured spectrophotometrically 
at 340 nm according to Pinto et al. (21). We followed 
NADPH oxidation using the extinction coeffi cient of 
6.22x103 L mol-1 cm-1. The incubation mixture 
contained 0.05 mol L-1 phosphate buffer, pH 7.4, 
2.5 mmol L-1 GSSG, and 125 μmol L-1 NADPH at 
30 °C. Enzyme activity is expressed in nmol min-1
mg-1 of protein.
Glutathione-S-transferase (GST) activity
GST activity was measured using CDNB as the 
substrate (22). The incubation mixture containing 
1.6 mL of 0.05 mol L-1 phosphate buffer, 100 μL of 
1 mmol L-1 GSH, 100 μL of 1 mmol L-1 EDTA, and 
100 μL of homogenate was incubated at 37 °C for 
15 min. After the incubation, 100 μL of 1 mmol L-1 
CDNB was added and the increase in absorbance with 
time was recorded at 340 nm. Enzyme activity was 
measured using the extinction coefficient of 
9.6x103 L mol-1 cm-1 and is expressed as nanomol of 
CDNB-GSH conjugate per minute per milligram of 
protein.
Statistical analysis
The statistical analysis was performed using 
MedCalc (MedCalc Software bvba, Mariakerke, 
Belgium). The signifi cance of the data was assessed 
using the non-parametric Mann-Whitney test. Values 
of p≤0.05 were considered statistically signifi cant.
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RESULTS
The results are expressed as means ±SEM for six 
rats per group. Figure 1 shows the levels of lipid 
peroxidation in the liver tissue of control animals and 
animals treated with myosmine and nicotine. MDA 
signifi cantly increased in the myosmine and nicotine-
treated groups after both i.p. injection (+31 % and 
+21 %, respectively; p≤0.05) and oral administration 
(+29 % and +33%, respectively; p≤0.05) in respect to 
control. 
The effects on CAT, SOD, and GPx are summarised 
in Figures 3-5. Signifi cant decreases in the activity of 
SOD and GPx were noted with both routes of 
myosmine exposure and were comparable with 
nicotine. However, myosmine signifi cantly increased 
CAT activity (24 % after i.p. injection and 19 % after 
oral administration; p≤0.05), while nicotine did the 
opposite; it decreased CAT by 22 % and 18 % (p≤0.05) 
after i.p.  injection and oral administration, 
respectively.
Figure 1  MDA concentration in rat liver 24 h after i.p. injection 
(□) or oral administration (■) of myosmine or 
nicotine. Values are presented as the mean ± SEM, 
n=6. *Signifi cant difference from control values 
(Mann-Whitney test, p<0.05)
Myosmine and nicotine treatment depleted GSH 
-36 % and -14 % after i.p. injection and -23 % and 
-28 % after oral administration, respectively (Figure 
2).
Figure 2  GSH level in rat liver 24 h after i.p. injection (□) or 
oral administration (■) of myosmine or nicotine. 
Values are presented as the mean ± SEM, n=6. 
*Signifi cant difference from control values (Mann-
Whitney test, p<0.05)
Figure 3  CAT activity in rat liver 24 h after i.p. injection (□) 
or oral administration (■) of myosmine or nicotine. 
Values are presented as the mean ± SEM, n=6. 
*Signifi cant difference from control values (Mann-
Whitney test, p<0.05)
Figure 4  SOD activity in rat liver 24 h after i.p. injection (□) 
or oral administration (■) of myosmine or nicotine. 
Values are presented as the mean ± SEM, n=6. 
*Signifi cant difference from control values (Mann-
Whitney test, p<0.05)
Figures 6 and 7 show the activities of GR and GST 
after myosmine and nicotine administration. Both 
signifi cantly increased GR activity through either 
Simeonova R, et al. MYOSMINE EFFECTS ON ANTIOXIDATIVE DEFENCE IN RAT LIVER









































route of administration, and to a similar extent, 28 % 
and 35 %, respectively (p≤0.05). Neither compound 
induced signifi cant changes in GST activity after either 
i.p. injection or oral administration.
neutralise reactive molecules by deploying their 
antioxidative defences that include reduced glutathione 
(GSH), alpha-tocopherol, ascorbic acid, and antioxidant 
enzymes catalase (CAT), superoxide dismutase 
(SOD), glutathione peroxidase (GPx), glutathione 
reductase (GR), and glutathione-S-transferase 
(GST).
The formation of reactive oxygen species (ROS) 
is stimulated by a number of xenobiotics and can result 
in oxidative stress and cellular injury. As myosmine 
is structurally similar to nicotine, which is known to 
induce oxidative stress (24), it is expected to act in a 
similar way. Its proclivity for oxidation reactions (6) 
may give rise to lipid peroxidation and cellular 
damage. In our study, a single dose of nicotine 
decreased GSH, SOD, CAT and GPx activities and 
increased MDA level and GR activity in rat liver. 
These results are in good agreement with the results 
of Sudheer et al. (26), who reported that nicotine 
subchronic administration resulted in significant 
decreases of enzymatic and non-enzymatic 
antioxidative defences in the liver, lung, and the 
circulation. Myosmine i.p. and oral treatment at 
equitoxic doses also led to signifi cant increases in 
MDA and GR and decreased the GSH level and SOD 
and GPx activities. In contrast to nicotine, myosmine 
increased CAT activity.
In vivo metabolism of myosmine has been 
investigated after oral administration in female Wistar 
rats by Zwickenpfl ug et al. (5). The authors identifi ed 
3-pyridylacetic acid (3-PAA) and 4-oxo-4-(3-pyridyl) 
butyric acid (keto acid) as the main metabolites and 
3-pyridylmethanol, 3-hydroxymyosmine and 4-
hydroxy-1-(3-pyridyl)-1-butanone (HPB) as minor 
Figure 7  GST activity in rat liver 24 h after i.p. injection (□) 
or oral administration (■) of myosmine or nicotine. 
Values are presented as the mean ± SEM, n=6.
Figure 5  GPx activity in rat liver 24 h after i.p. injection (□) 
or oral administration (■) of myosmine or nicotine. 
Values are presented as the mean ± SEM, n=6. 
*Signifi cant difference from control values (Mann-
Whitney test, p<0.05) difference 
Figure 6  GR activity in rat liver 24 h after i.p. injection (□) 
or oral administration (■) of myosmine or nicotine. 
Values are presented as the mean ± SEM, n=6. 
*Signifi cant difference from control values (Mann-
Whitney test, p<0.05)
DISCUSSION
Oxidative stress is an imbalance between the 
production and scavenging of ROS and free radicals 
that can induce lipid peroxidation, DNA fragmentation, 
and protein oxidation (23). These damages result in 
the loss of membrane integrity, structural and 
functional changes in proteins and gene mutations 
(24). Normally, the affected cells are trying to 
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metabolites. The relatively high amount of 3-PAA 
(23 %) suggests that myosmine undergoes a 
biochemical transformation in the rat stomach (27), 
leading to free radical formation. The increase in MDA 
level detected in our study may be related to the 
increase in free radical formation. De Zwart et al. (28) 
reported that lipid peroxidation produced several toxic 
byproducts such as MDA, which can attack cellular 
targets including DNA, inducing mutagenicity and 
carcinogenicity. The increased MDA level after 
myosmine treatment, might also contribute to the 
mutagenic and genotoxic effects of myosmine (9, 29-
31). Glutathione is required to maintain the normal 
reduced state of cells and to counteract the adverse 
effects of oxidative stress. It is involved in many 
cellular processes including the detoxification of 
endogenous and exogenous compounds and can be 
monitored as a nonspecific indicator of cellular 
toxicity. The increased lipid peroxidation in myosmine-
treated rats can be regarded as a key event for the 
observed GSH depletion after i.p.  and oral 
administration (see Figure 2). Furthermore, 
Zwickenpflug and Tyroller (6) suggested that 
myosmine peroxidation to 3-pyridylmethanol, 
nornicotyrine, HPB, and keto acid produced highly 
reactive electrophilic intermediates known as 
epoxides, and we believe that these electrophiles 
interact with the large nucleophilic pool of GSH in 
the liver and deplete it.
In addition to increased lipid peroxidation and 
decreased GSH level, myosmine significantly 
decreased the activities of the antioxidant enzymes 
SOD and GPx (see Figures 3 and 5 respectively) and 
increased CAT activity (see Figure 4). These enzymes 
act together and constitute the enzymatic antioxidative 
defence mechanism against reactive oxygen species 
(32). The SOD dismutates superoxide radicals (O2.
-) 
into hydrogen peroxide (H2O2) and O2. Catalase further 
detoxifi es H2O2 into H2O and O2 (33). Glutathione 
peroxidase, similar to CAT, detoxifi es H2O2. Lower 
SOD and GPx activities in our study could be 
attributed to several mechanisms. The fi rst is their 
overconsumption in inactivating the reactive 
intermediates generated during the metabolism of 
myosmine. The second is that oxidative stress could 
inactivate enzyme proteins through these intermediates 
or could be a consequence of lower de novo synthesis 
of enzyme proteins. The increased hepatic CAT 
activity may be a compensatory mechanism to get rid 
of excess peroxides due to low GPx activity. The third 
is that the activation of myosmine by peroxidative or 
n i t r o s a t i v e  m e c h a n i s m s  c o u l d  l e a d  t o 
pyridyloxobutylation of proteins, DNA, and RNA (6, 
8, 30) and could compromise their functioning.
The signifi cant increase in GR (see Figure 6) could 
be attributed to increased GSSG production, which 
we have not measured in this study but which is 
reasonable to assume (23).
Our study confirms that single i.p. and oral 
administration of myosmine signifi cantly increases 
lipid peroxidation and compromises the enzymatic 
and non-enzymatic antioxidative defence systems. Its 
pro-oxidant effects are comparable with those of 
nicotine.
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Sažetak
DJELOVANJE MIOZMINA NA ANTIOKSIDATIVNE SUSTAVE U JETRI ŠTAKORA
Miozmin (3-(1-pirolin-2-il)piridin) alkaloid je strukturno sličan nikotinu, za koji se zna da potiče oksidativni 
stres. Istražili smo djelovanje miozmina na enzimske i neenzimske antioksidativne sustave u jetri štakora. 
Wistar štakori primili su jednokratno pokusni spoj intraperitonealno u dozi od 19 mg kg-1, odnosno na usta 
u dozi od 190 mg kg-1. Za pozitivnu kontrolu rabili smo nikotin.
Nakon primjene, bez obzira na put, zamijećena je promjena u jetrenoj funkciji u obliku pada razina 
glutationa, aktivnosti superoksid dismutaze i glutation peroksidaze te rasta razina malondialdehida, 
aktivnosti katalaze i glutation reduktaze. Ovi nalazi upućuju na to da intraperitonealna i oralna primjena 
miozmina dovode do značajne lipidne peroksidacije u jetrenome tkivu te promjena u enzimskoj i 
neenzimskoj zaštiti jetre. Prooksidativno djelovanje miozmina pokazalo se sličnim onomu nikotina.
KLJUČNE RIJEČI: duhanski alkaloid, glodavci, lipidna peroksidacija, oksidativni stres
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